Overall, our study underscores the significance of EphB4 and ephrinB2 signaling pathways in HNSCC metastasis and highlights the therapeutic potential of targeting this axis to disrupt metastasis in HPV-unrelated HNSCC. Here, EPHB4 is linked to head and neck squamous cell carcinoma.